natgillin/translations-raw huggingface dataset:
Adjustment for these baseline factors resulted in a treatment hazard ratio of 0.78 (95% CI [0.63; 0.96], p=0.0219), indicating a 22% reduction in the risk of death for patients in the Avastin + IFN alfa-2a arm compared to IFN alfa-2a arm.
Po prilagoditvi glede na izhodiščne dejavnike je bilo razmerje ogroženosti 0,78 (95-% interval zaupanja [0,63; 0,96], p = 0,0219), kar je pomenilo 22 % zmanjšanje tveganja za smrt za bolnike, ki so prejemali zdravilo Avastin in interferon alfa-2a, v primerjavi z bolniki, ki so prejemali interferon alfa- 2a.
adjustment has not been evaluated
valproata je potrebno pri bolnikih
Adjustment of dosage may also be necessary if patients change physical activity or their usual diet.
Prilagoditev odmerjanja utegne biti potrebna tudi v primeru, ce bolniki spremenijo svojo telesno dejavnost ali obicajno prehrano.
Adjustment of dosage may also be necessary if patients undertake increased physical activity or change their usual diet.
Odmerjanje je morda treba prilagoditi tudi, če bolnik poveča telesno dejavnost ali spremeni običajni način prehrane.
adjustment of escitalopram
Prilagoditev
adjustment of maraviroc is not required.
Študije populacijske farmakokinetike kažejo, da odmerka maraviroka ni treba prilagajati.
adjustment of oral contraceptives is necessary
sočasni uporabi z dolutegravirjem prilagajanje
adjustment of rifabutin to be
uporabljenega okrepljenega
adjustment of tenofovir.
emtricitabin
adjustment of the
prilagoditev odmerka
Adjustment of the posology
Prilagajanje odmerjanja
Adjustment of the sapropterin dose or modification of dietary phenylalanine intake may be required to achieve and maintain blood phenylalanine levels within the desired therapeutic range.
Da bi dosegli in ohranili raven fenilalanina v krvi znotraj želenega terapevtskega območja, je lahko potrebna prilagoditev odmerka sapropterina ali sprememba vnosa fenilalanina s hrano.
Adjustment of the Trobalt dose is recommended in patients with moderate to severe renal impairment but no adjustment of the Trobalt dose is recommended in patients with mild renal impairment (see section 4.2).
Prilagoditev odmerka zdravila Trobalt se priporoča pri bolnikih z zmerno do resno okvaro ledvic, vendar pri bolnikih z blago okvaro ledvic prilagoditev odmerka zdravila Trobalt ni potrebna (glejte poglavje 4.2).
adjustment should be considered,
je potrebna previdnost.
Adjustment steps (every
koraki za prilagajanje (vsakih
adjustment.
brez prilagajanja odmerkov.
adjustment.
odmerka.
adjustment.
prilagoditve odmerka.
adjustment.
uporabljajo brez prilagajanja
Adjustment: 13C/12C-ratio with respect to Pee Dee Beliminate (PDB)
Nastavitev: Razmerje med 13C in 12C glede na standard PDB (Pee Dee Belemnite)
adjustments (see also
uporabljajo brez prilagajanja
Adjustments in dose regimen of the medicinal product, meal patterns, or physical activity may be needed.
Potrebne so lahko prilagoditve odmerka zdravila, razporeda obrokov ali telesne dejavnosti.
Adjustments in dose regimen of the medicinal product, meal patterns, or physical activity may be needed.
Potrebne utegnejo biti prilagoditve odmerka zdravila, razporeda obrokov ali telesne dejavnosti.
Adjustments in the dose of valproic acid and Intuniv may be indicated when co- administered.
Pri sočasnem dajanju valproične kisline in zdravila Intuniv bo mogoče treba prilagoditi njuna odmerka.
Adjustments of insulin dose if required should usually be done between 0.5 to 1 IU per injection.
Če je odmerek insulina treba prilagoditi, se ga običajno prilagodi za 0,5 do 1 i.e. na injekcijo.
Adjustments of the daily dose of tenofovir disoproxil (as fumarate) 33 mg/g granules are recommended in patients with moderate (creatinine clearance 30-49 ml/min) or severe (creatinine clearance < 30 ml/min) renal impairment based on modelling of single-dose pharmacokinetic data in HIV negative and non-HBV infected subjects with varying degrees of renal impairment, including end-stage renal disease requiring haemodialysis.
Prilagoditev dnevnega odmerka dizoproksiltenofovirata (v obliki dizoproksiltenofovirijevega fumarata) 33 mg/g zrnca se priporoča pri bolnikih z zmerno (očistek kreatinina 30-49 ml/min) ali hudo (očistek kreatinina < 30 ml/min) ledvično okvaro, ki temelji na podatkih farmakokinetičnega modeliranja enkratnih odmerkov pri bolnikih, ki so HIV-negativni in niso okuženi z virusom HBV, z različnimi stopnjami ledvične okvare, vključno s končno fazo ledvične bolezni, zaradi katere je potrebna hemodializa.
Adjustments to the targeted range should be made according to the assay being utilised to determine the sirolimus trough concentrations.
Tarčni razpon moramo prilagajati v skladu z metodo, ki smo jo uporabili za določanje najnižjih koncentracij sirolimusa.
adjustments, however, the
vendar pa bo morda potrebna
adjustments.
brez prilagajanja odmerkov.
adjustments.
dizoproksiltenofovirat
adjustments.
odmerkov.
adjustments.
prilagoditve odmerka.
adjustments.
uporabljajo brez prilagajanja
Adjuvant
Dodatek
Adjuvant
Dodatki
Adjuvant emulsion for Arepanrix I.M.
Emulzija adjuvansa za Arepanrix i.m.
Adjuvant emulsion for injection 25 vials: emulsion
emulzija adjuvansa za injiciranje 25 vial: emulzija
Adjuvant emulsion for Pandemrix I.M.
Emulzija adjuvansa za cepivo Pandemrix i.m.
Adjuvant emulsion for Pumarix I.M.
Emulzija adjuvansa za cepivo Pumarix i.m.
Adjuvant for HUMENZA emulsion for injection
Adjuvans za emulzijo za injiciranje za cepivo HUMENZA
Adjuvant for HUMENZA emulsion for injection IM
Adjuvans za emulzijo za injiciranje za cepivo HUMENZA i.m.
Adjuvant MF59C.1 containing:
Adjuvans MF59C.1 vsebuje:
Adjuvant MF59C.1 containing:
kvalen 9,75 miligramov
Adjuvant vial: Sodium chloride Potassium chloride
Viala z adjuvansom: natrijev klorid kalijev klorid
Adjuvant(s):
Dodatek(Dodatki):
Adjuvant:
Ajduvans:
Adjuvant:
Dodatek :
Adjuvant:
Pomožna snov
Adjuvant:
Pomožna snov:
Adjuvant: 250 (225-275) μg saponin (from the solvent)
Dodatek: 250 (225-275) μg saponina (v topilu)
Adjuvant: dl-α-tocopherol acetate 150 mg
Adjuvans: dl-alfa-tokoferol acetat 150 mg
Adjuvant: dl--tocopherol acetate 150 mg For a full list of excipients, see section 6.1.
Adjuvans dl-alfa-tokoferol acetat 150 mg Celoten seznam pomožnih snovi, glej razdelek 6.1.
Adjuvant: MF59C.1 oil composed of squalene, polysorbate 80 and sorbitan trioleate.
Adjuvans: MF59C.1 olje, ki ga sestavljajo skvalen, polisorbat 80 in sorbitan trioleat.
Adjuvant: MF59C.1 oil in water emulsion containing squalene, as the oil phase, stabilised with polysorbate 80 and sorbitan trioleate in a citrate buffer.
Adjuvans: MF59C.1 emulzija olja v vodi, ki vsebuje skvalen kot oljno fazo in je stabilizirana s polisorbatom 80 in sorbitantrioleatom v citratnem pufru.
Adjuvant:Liquid light paraffin 234.8 mg
Tekoči lahki parafin, 234,8 mg
Adjuvants
Dodatki
Adjuvants are used to improve the body’s response to the vaccine.
Adjuvans se uporablja zato, da okrepi telesni imunski odziv na cepivo.
Adjuvants are used to improve the body’s response to the vaccine.
Adjuvansi se uporabljajo za izboljšanje imunskega odziva na cepivo.
Adjuvants:
Dodatek(dodatki):
Adjuvants:
Dodatek:
Adjuvants: Aluminium hydroxide Saponin
Dodatka: Aluminijev hidroksid Saponin
Adjuvated solvent for Nobivac Piro.
Vehikel z dodatkom za Nobivac Piro
Administer 0.1 mg firocoxib per kg bodyweight, once daily.
Enkrat dnevno dajte 0,1 mg/kg telesne mase firokoksiba.
Administer 0.25 – 0.5 mg osaterone acetate per kilogram bodyweight, once a day, for 7 days as follows:
Odmerite 0,25 – 0,5 mg osateronijevega acetata na kilogram telesne teže enkrat na dan 7 dni na naslednji način:
Administer 0.6 mg/kg body weight, once daily for up to 14 days.
Odmerek 0,6mg/kg telesne mase se daje enkrat dnevno, do 14 dni.
Administer 1 dose (0.5 ml) of the veterinary medicinal product to rabbits at the age of 30 days by subcutaneous injection in the lateral thoracic wall.
Uporabite 1 odmerek (0.5 ml) cepiva za kunce pri starosti 30 dni in ga vbrizgajte pod kožo v bočno torakalno steno.
Administer 1 dose (0.5 ml) to rabbits at the age of 30 days by subcutaneous injection in the lateral thoracic wall.
Uporabite 1 odmerek (0.5 ml) cepiva za kunce pri starosti 30 dni in ga vbrizgajte pod kožo v bočno torakalno steno.
Administer 1000 Units (reconstituted in 10 ml of water for injections) of Cinryze by intravenous injection (into the vein) at a rate of 1 ml per minute over 10 minutes.
Bolniku dajte 1000 enot (rekonstituiranih v 10 ml vode za injekcije) zdravila Cinryze intravensko (v veno) s hitrostjo 1 ml na minuto v 10 minutah.
Administer 1000 Units (reconstituted in 10 ml of water for injections) of Cinryze by intravenous injection at a rate of 1 ml per minute over 10 minutes.
Bolniku dajte 1000 enot (rekonstituiranih v 10 ml vode za injekcije) zdravila Cinryze intravensko s hitrostjo 1 ml na minuto v 10 minutah.
Administer a single vial as an infusion.
Dajte le eno vialo v obliki infuzije.
Administer at 25 mg/hr over 4 hours.
Uporabite s hitrostjo 25 mg/uro v 4 urah.
Administer at 50 mg/hr.
Začnite s hitrostjo 50 mg/uro.
administer dinutuximab at 0.875 mg/m2/h and full dose GM-CSF or IL- 2.
ciklom, aplicirajte 0,875 mg/m2/h dinutuksimaba in celotni odmerek GM-CSF ali IL-2.
Administer dinutuximab at 0.875 mg/m2/h and resume GM-CSF or IL-
Aplicirajte 0,875 mg/m2/h dinutuksimaba in ponovno začnite z
Administer dose by gently squeezing liquid into infant's mouth toward the inner cheek until dosing tube is empty. (A residual drop may remain in the tip of the tube.)
Odmerek aplicirajte tako, da nežno iztisnete tekočino v otrokova usta v smeri proti notranji strani lica, dokler odmerna tuba ni prazna (v konici tube lahko ostane kapljica raztopine).
Administer every 3 months
odmerjanje na 3 mesece
Administer Hizentra under the skin only.
Zdravilo Hizentra dajajte samo pod kožo.
Administer in accordance with the following table:
Odmerke določimo po naslednji tabeli:
Administer in the posterior part of the ear base (see Figure 1).
Aplicirajte v posteriorni del baze ušesa (glej sliko 1).
Administer intramuscularly slowly (1-2 minutes/injection) into the buttock (gluteal area).
Počasi (1-2 minuti/injekcijo) injicirajte intramuskularno v glutealni predel.
Administer LEMTRADA infusion solution via intravenous administration over approximately 4 hours.
Infuzijska raztopina zdravila LEMTRADA se daje intravensko v obdobju približno štirih ur.
administer lopinavir/ritonavir and
lopinavirja/ritonavirja s
Administer once weekly (ml)
Za uporabo enkrat na teden (ml)
Administer one 2 ml dose by deep intramuscular injection in accordance with the following vaccination scheme:
Odmerek po 2 ml dajte globoko intramuskularno, po naslednji shemi cepljenja:
Administer one dose (1 ml of ProteqFlu), by intramuscular injection, preferably in the neck region, according to the following schedule:
Injicirajte 1 odmerek (1 ml Proteqflu) intramuskularno, priporočljivo v predel vratu, po naslednjem razporedu:
Administer one dose (1 ml) by intramuscular injection, according to the following schedule:
En odmerek (1 ml) intramuskularno po naslednji shemi:
Administer one dose (1 ml), by intramuscular injection, preferably in the neck region, according to the following schedule:
Injicirajte 1 odmerek (1 ml) intramuskularno, priporočljivo v predel vratu, po naslednjem razporedu:
Administer one dose (1 ml), by intramuscular injection, preferably in the neck region, according to the following schedule:
Injicirajte 1 odmerek intramuskularno, priporočljivo v predel vratu, po naslednjem razporedu:
Administer one dose (1ml), by intramuscular injection, according to the following schedule:
Po en odmerek (1 ml) intramuskularno po naslednji shemi:
Administer one dose (1ml), by strict intramuscular injection, according to the following schedule:
Po en odmerek (1 ml) strogo intramuskularno po naslednji shemi:
Administer one dose (2 ml) by deep intramuscular injection in the neck area behind the ear.
Injicirajte 2 ml cepiva globoko intramuskularno v vratni predel za ušesom.
Administer one dose (2 ml) by subcutaneous injection in the neck (at the front of the shoulder), according to the following regimen:
Injicirajte en odmerek (2 ml) v podkožje v predelu vratu na prednjem delu rame po naslednjem režimu:
Administer one dose of 1 ml according to the following vaccination scheme:
Injicirajte 1 odmerek (1 ml) cepiva subkutano po naslednjem razporedu:
Administer one dose of 1 ml according to the following vaccination scheme: Primary vaccination course: 1 injection from 12 weeks of age,
Injicirajte 1 odmerek (1 ml) cepiva subkutano po naslednjem razporedu:
Administer one dose of 1ml according to the following schedule: Basic vaccination: first injection: from 8 weeks of age, second injection: 3 to 5 weeks later.
Osnovno cepljenje: prvi odmerek: od osmega tedna starosti dalje, drugi odmerek: 3 do 5 tednov pozneje.
Administer one dose of 2 ml according to the following vaccination scheme:
Dajte en odmerek (2 ml) v skladu z naslednjim programom cepljenja:
Administer one dose of 2 ml according to the following vaccination scheme: 1st injection: from 2.5 months of age.
Dajte en odmerek (2 ml) v skladu z naslednjim programom cepljenja:
Administer one dose of 2 ml by intramuscular injection in the neck muscles
En 2 ml odmerek dajte z intramuskularno injekcijo v vratno mišičevje.
Administer one dose of 2 ml by intramuscular injection in the neck muscles according to the following schedule:
En odmerek (2 ml) aplicirajte z intramuskularno injekcijo v vratno mišičevje po naslednjem razporedu:
Administer one implant only, irrespective of the size of the dog.
Dajajte samo po en implantat, ne glede na velikost psa.
Administer one implant only.
Dajajte samo po en implantat.
Administer one tube per infected ear.
V vsako vneto uho aplicirajte eno tubo.
Administer only to fasted dogs.
Zdravilo damo psu na tešče.
Administer orally (i.e. into the child’s mouth, towards the inner cheek) the entire content of the oral applicator.
Celotno vsebino peroralnega aplikatorja aplicirajte peroralno (tako, da aplicirate celotno vsebino peroralnega aplikatorja na notranjo stran lica).
Administer orally with a suitable dose device.
Dajajte peroralno s primernim pripomočkom za odmerjanje.
Administer peginterferon alfa and ribavirin and finish through
TZ, nato uporabljajte peginterferon alfa in ribavirin ter zaključite do konca 48.
Administer reconstituted Abraxane suspension intravenously using an infusion set incorporating a 15 µm filter.
Rekonstituirano suspenzijo zdravila Abraxane dajajte intravensko z infuzijskim sistemom, ki vključuje 15 µm filter.
Administer Rienso as an infusion as follows: o 510 mg (one vial) diluted in 50-250 ml of sterile 0.9% sodium chloride or sterile 5% glucose, administered for at least 15 minutes (concentration of 2-8 mg iron per ml).
Zdravilo Rienso dajte v obliki infuzije, kot sledi: o 510 mg (ena viala), razredčena v 50‒250 ml sterilne 0,9-odstotne raztopine natrijevega klorida ali sterilne 5-odstotne raztopine glukoze, ki se daje najmanj 15 minut (v koncentraciji 2‒8 mg železa na ml).
Administer solution slowly intravenously (see section 4.2), taking care to ensure that no blood enters the syringe filled with product.
Raztopino injicirajte počasi intravensko (glejte poglavje 4.2), poskrbite, da v brizgo, napolnjeno z zdravilom, ne vstopi kri.
Administer solution which is at room or body temperature.
Uporabljajte raztopino, segreto na sobno ali telesno temperaturo.
Administer subcutaneously one dose of the veterinary medicinal product according to the following regimen of vaccination.
En odmerek zdravila za uporabo v veterinarski medicini dajte subkutano po naslednjem programu cepljenja.
Administer subcutaneously one dose of the veterinary medicinal product according to the following regimen of vaccination.
Odmerek zdravila za uporabo v veterinarski medicini aplicirajte subkutano po naslednjem programu cepljenja.
Administer suitable local anaesthetic, if desired.
Pred modeliranjem se lahko po želji uporabi lokalni anestetik.
Administer suitable local anesthetic, if desired.
Po želji uporabite ustrezni lokalni anestetik.
Administer supportive measures (see section 4.4).
Nudite podporne ukrepe (glejte poglavje 4.4).
Administer supportive measures.
Nudite podporne ukrepe.
Administer the amount required..
Vbrizgajte si določeni odmerek.
Administer the diluted solution by intravenous infusion using an infusion set fitted with a flow regulator and with an in-line, sterile, non-pyrogenic, low protein-binding polyethersulfone (PES) filter (pore size 0.22 or 0.2 micrometre).
Razredčeno raztopino injicirajte z intravensko infuzijo z uporabo infuzijskega kompleta z regulatorjem pretoka in linijskim sterilnim apirogenim polietersulfonskim (PES) filtrom, ki minimalno veže proteine (z velikostjo por 0,22 ali 0,2 mikrometra).
Administer the human normal immunoglobulin 10% at the rates prescribed by your healthcare professional.
Infundirajte humani polispecifični imunoglobulin 10 %:
Administer the infusion solution intravenously over 30 minutes using a sterile, non-pyrogenic, low-protein binding 0.2 to 5 µm in-line or add-on filter.
Raztopino za infundiranje aplicirajte intravensko v 30 minutah, skozi sterilen, nepirogen, 0,2 do 5 µm linijski ali dodatni filter, ki minimalno veže beljakovine.
Administer the infusion solution over a period of 40 minutes using an intravenous line with an integral filter.
Raztopino infundirajte 40 minut in za to uporabite intravenski kanal z vgrajenim filtrom.
Administer the OPDIVO infusion intravenously over a period of 60 minutes.
OPDIVO raztopino za infundiranje morate aplicirati v obliki 60-minutne intravenske infuzije.
Administer the oral suspension immediately after preparation.
Peroralno suspenzijo je treba uporabiti takoj po pripravi.
Administer the suspension into the mouth of the dog.
Suspenzijo iztisnite psu v usta.
Administer the veterinary medicinal product with caution to avoid self-injection.
Zdravilo dajajte previdno, da se izognete samo- injiciranju.
Administer the whole contents of the syringe into the inside of the upper lip (see Figure 3).
Izbrizgajte vso vsebino brizge (glejte sliko 3).
Administer the YERVOY infusion intravenously over a period of 90 minutes.
Zdravilo YERVOY morate aplicirati v obliki 90-minutne intravenske infuzije.
Administer two vaccinations of 1 dose (1 ml) of vaccine with an interval of 4 weeks to dogs from 6 weeks of age onwards.
Pse cepite od 6 tednov starosti dalje dvakrat s po 1 odmerkom (1 ml) z razmikom 4 tednov.
Administer two vaccinations of 1 dose (1 ml) of vaccine with an interval of 4 weeks to dogs from 6 weeks of age onwards.
Pse od 6 tednov starosti dalje cepite dvakrat s po 1 odmerkom (1 ml) z razmikom 4 tednov.
Administer using aseptic procedures.
Pri vnosu cepiva se ravnajte v skladu s pravili asepse.
Administer via a central venous line, including a central venous catheter or peripherally inserted central catheter (PICC) by slow intravenous infusion over approximately 90 minutes.
Zdravilo dajte po centralni venski liniji, ki vključuje centralni venski kateter ali periferno vstavljen centralni kateter (PICC), v počasni intravenski infuziji približno 90 minut.
Administer your next dose immediately and continue at regular intervals as advised by your doctor.
Takoj uporabite vaš naslednji odmerek in zdravljenje nadaljujte v rednih presledkih, kot vam je predpisal zdravnik.
administered
(0,89-1,37)
administered 1 hour before or
zato ga je potrebno zaužiti 1 uro
administered 30 minutes before
4 dni, dan 30 minut pred
Administered as Atripla
Uporabljeno kot zdravilo Atripla
Administered as Epclusa.
Uporabljeno kot zdravilo Epclusa.
Administered as Harvoni.
Uporabljeno kot zdravilo Harvoni
administered at least one
razmiku vsaj ene ure, na
administered at the same
ombitasvir/paritap
administered chronically
uporabi v odmerkih, ki se
Administered concomitantly with levodopa and an aromatic amino acid decarboxylase inhibitor (AADC-I), it leads to more stable plasma levels of levodopa by reducing metabolism of levodopa to 3-methoxy-4-hydroxy-L-phenylalanine (3-OMD).
Če je dan sočasno z levodopo in zaviralcem aromatske aminokislinske dekarboksilaze (AADC-I), omogoča bolj stabilne plazemske vrednosti levodope z zmanjšanjem presnove levodope v 3-metoksi- 4-hidroksil-L-fenilalanin (3-OMD).
Administered in two divided doses, in the morning and in the evening.
Dajanje v dveh deljenih odmerkih zjutraj in zvečer.
administered Medicinal Products (mg)
očasno zdravila
administered midazolam is
ritonavirja s peroralno obliko
Administered volume (nominal pipette size, ml)
Vsebnost osnovne merilne kapalke v ml
Administered volume (nominal pipette size, ml)
Vsebnost osnovne merilne kapalke, ml
administered with
na dan)
administered with
Prilagoditi ga je treba na
administered with
samo z ritonavirjem, se
administered with
uporabi z zdravilom
administered with atazanavir, a
njegovemu presnovku dezacetil
administered with EVOTAZ and a
Odmerek antagonista
administered with Exviera
sulfasalazin daje
administered with Invirase/ritonavir.
uporabljen v študiji)
administered with Kaletra.
zdravilom Kaletra se
administered with low dose
hkratnih majhnih odmerkih
administered with low dose
Imunosupresivi
administered with low dose
ob ritonavirju paranteralno dajemo
administered with low dose
ritonavirja v majhnihh odmerkih
administered with nelfinavir.
nelfinavirjem ne smemo dajati.
administered with parenteral
ob ritonavirju paranteralno dajemo
administered with tenofovir, it is
očasni uporabi tenofovirja je
administered with Viekirax with or without dasabuvir.
potrebna, kadar se sočasno daje s kombinacijo Viekirax z ali brez dasabuvirja.
administered with Viekirax with or without dasabuvir.
zdravilom Viekirax z
administered with voriconazole,
vorikonazola je treba vzdrževalni
administered without dose adjustments.
Maravirok in zdravilo Viramune lahko dajemo sočadno brez prilagajanja odmerkov.
administered.
lopinavirjem/ritonavirjem.
administering carbamazepine or
ali prenehali jemati zdravilo
administering phenytoin with
inhibicije P-gp z zdravilom
administering phenytoin with
Pri uporabi fenitoina z zdravilom
Administering with liquid
Uporaba s tekočino
administration
(koncen
Administration
(koncentracija)
ADMINISTRATION
APLICIRANJE ZDRAVILA
administration
aplikacije
administration
bolečine v medenici
administration
dajanja
Administration
Dajanje
ADMINISTRATION
DAJANJE ZDRAVILA
administration
dajanjem zdravil
Administration
dovoljenja za promet
Administration
EU/1/01/185/044
administration
infundiranja,
Administration
Infundiranje zdravila
Administration
Injiciranje
administration
izpuščaj
ADMINISTRATION
MESTU APLIKACIJE
Administration
na uporaba
Administration
Nacin uporabe
Administration
Način jemanja
Administration
Način uporabe
administration
Način uporabe zdravila
administration
oblika
Administration
pakiranja
Administration
pot uporabe
administration
Pot uporabe zdravila
administration
premembe
Administration
promet
administration
telesna
Administration
Uporaba cepiva
Administration
uporabe
Administration
zdravila
administration
zdrčavila
administration (each administration to be given
tablet za posamezno dajanje (zdravilo se daje
administration (each administration to be given morning and evening)
Število 150- in/ali 500-mg tablet za posamezno dajanje (zdravilo se daje zjutraj in zvečer)
Administration (implantation)
uporaba (vsaditev),
Administration (Intravenous Infusion):
Uporaba (intravensko infundiranje):
Administration and mechanical activation procedure
Način uporabe in postopek mehanske aktivacije
Administration and monitoring guide
Priročnik o uporabi zdravila in spremljanju bolnikov
Administration by continuous infusion has not been approved and is not recommended (see also sections 4.4 and 6.6).
Dajanje s kontinuirano infuzijo ni odobreno in ni priporočljivo (glejte tudi poglavji 4.4 in 6.6).
ADMINISTRATION EVERY 2 WEEKS
ZA UPORABO VSAKA 2 TEDNA GLEJTE PREGLEDNICO 3